Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets: 2013-2025

Historic Return on Assets for Agios Pharmaceuticals (AGIO) over the last 12 years, with Sep 2025 value amounting to -0.28%.

  • Agios Pharmaceuticals' Return on Assets fell 81.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year decrease of 81.00%. This contributed to the annual value of 0.52% for FY2024, which is 84.00% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Return on Assets stood at -0.28% for Q3 2025, which was down 165.86% from 0.43% recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Return on Assets ranged from a high of 1.32% in Q4 2021 and a low of -0.45% during Q2 2024.
  • Over the past 3 years, Agios Pharmaceuticals' median Return on Assets value was -0.30% (recorded in 2023), while the average stood at -0.06%.
  • In the last 5 years, Agios Pharmaceuticals' Return on Assets skyrocketed by 148bps in 2021 and then slumped by 163bps in 2022.
  • Quarterly analysis of 5 years shows Agios Pharmaceuticals' Return on Assets stood at 1.32% in 2021, then crashed by 163bps to -0.31% in 2022, then dropped by 5bps to -0.37% in 2023, then surged by 75bps to 0.39% in 2024, then crashed by 81bps to -0.28% in 2025.
  • Its Return on Assets stands at -0.28% for Q3 2025, versus 0.43% for Q2 2025 and 0.41% for Q1 2025.